|Description||This active molecular is a selective renal outer medullary potassium channel (RMOK) inhibitor originated by Merck Sharp & Dohme for the treatment of hypertension and heart failure. RMOK is an ATP-dependent potassium channel that transports potassium out of cells. MK-7145 is selective against other cardiac ion channels such as Cav1.2 and Nav1.5 with IC50 value > 30 μM. MK-7145 is the first small molecule ROMK inhibitor to enter clinical development. But in Feb 2015, Merck terminated a phase I trial in Hypertension in Australia and New Zealand.|
|Solubility||Soluble in DMSO|
|Application||hypertension and heart failure|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Current Developer||Originator： Merck Sharp & Dohme|
Chromanol 293B is a specific slow delayed rectifier K+ current (IKs) blocker with an IC50 value of 6.89 μM in xenopus oocytes expressing rat. It shows no activi...
ML 297 is a Kir3.1/3.2 (GIRK1/2) channel activator with IC50 values of 160, 887 and 914 nM for GIRK1/2, GIRK1/4 and GIRK1/3.
S 9947 is a Kv1.5 or IKur channel blocker exhibiting a dual inhibitory effect against cloned (Kv1.5) and native (IKur) cardiac potassium current.
DMP 543 is an acetylcholine release stimulator and a K-ATP channel blocker. It significantly enhances K+-stimulated [3H]-ACh release from rat hippocampal slices...
ML277, a sulfonylpiperidine compound, has been found to be a KCNQ1 K+ channel activator and could be used in the study of the activity of K+ channel in human ca...
Y-26763 is a Kir6 (KATP) channel opener and active metabolite of Y-27152. Y-26763 inhibits glucose-induced insulin secretion in isolated human pancreatic β-cell...
1-EBIO is an activator of epithelial KCa channels, and it stimulates a large and sustained trans-epithelial Cl- secretory response across T84 monolayers. 1-EBIO...
Amiodarone, an iodine-rich benzofuran derivative, as a vaughan-Williams Class III antiarrhythmic agent it is an ATP-sensitive potassium channel inhibitor (IC50=...
AZD1305 is a potassium channel and sodium channel antagonist. It can inhibit rapidly the activating delayed-rectifier potassium current, L-type calcium current,...
Psora 4 is the most potent small-molecule Kv1.3 blocker known. It blocked Kv1.3 in a use-dependent manner, with a Hill coefficient of 2 and an EC50value of 3 nM...
A Kv11.1 (hERG) channel blocker. Azimilide is a class III antiarrhythmic drug and it can be used to control abnormal heart rhythms.
Senicapoc, previously called as ICA 17043, is a is a small organic potent and selective blocker of the Gardos channel which is the calciumactivated potassium ch...
HMR 1098 is a KATP channel antagonist inactivating the ATP-sensitive potassium channels (KATP) responsible for potassium efflux. HMR 1098 is an inhibitor of Kir...
MK 499, also know as L706000, has been found to be a potassium channel antagonist that has been once studied the activity in the treatment of arrhythmias. The P...
Vernakalant hydrochloride, also known as RSD1235, is a novel, relatively atrial-selective antiarrhythmic drug which can terminate acute atrial fibrillation (AF)...
ADWX 1 has been found to be a Kv1.3 channel blocker and could probably ameliorate autoimmune encephalomyelitis at some extent.
Tertiapin-Q, a derivative of the bee venom toxin tertiapin, is a high affinity blocker of inward-rectifier K+ channels. Tertiapin-Q binds to ROMK1 (Kir1.1) and ...
NS 1619, a benzimidazalone derivative, activates BKca channels in a number of tissues. However, the effect of NS 1619 was dependent upon the presence of Ca 2+ i...
ML252 is a selective and brain penetrant KCNQ2 inhibitor (Kv7.2; IC50 value 69 nM) used in vivo to study KCNQ2 pharmocology.
Vonoprazan is a first-in-class potassium-competitive acid blocker (P-CAB) reversibly inhibiting gastric H+, K+-ATPase. It can be used for the treatment of gastr...